Geoffrey O'Brien
2021
In 2021, Geoffrey O'Brien earned a total compensation of $1.1M as Vice President at MediciNova, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $66,107 |
|---|---|
| Option Awards | $648,108 |
| Salary | $343,413 |
| Other | $17,400 |
| Total | $1,075,028 |
O'Brien received $648.1K in option awards, accounting for 60% of the total pay in 2021.
O'Brien also received $66.1K in non-equity incentive plan, $343.4K in salary and $17.4K in other compensation.
Rankings
In 2021, Geoffrey O'Brien's compensation ranked 8,545th out of 12,406 executives tracked by ExecPay. In other words, O'Brien earned more than 31.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,545 out of 12,406 | 31st |
Division Manufacturing | 3,790 out of 5,494 | 31st |
Major group Chemicals And Allied Products | 1,677 out of 2,369 | 29th |
Industry group Drugs | 1,492 out of 2,090 | 29th |
Industry Pharmaceutical Preparations | 1,111 out of 1,537 | 28th |
Source: SEC filing on April 26, 2022.
O'Brien's colleagues
We found two more compensation records of executives who worked with Geoffrey O'Brien at MediciNova in 2021.